遺伝子検査市場規模、シェア、成長分析：技術別、用途別、製品別、チャネル別、最終用途別、地域別 - 産業予測 2025～2032年

遺伝子検査の世界市場規模は2023年に80億米ドルと評価され、2024年の98億4,000万米ドルから2032年には515億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは23.0％で成長する見通しです。

遺伝子検査市場は、テクノロジーの進歩、ヘルスケア需要の増加、一般市民の意識の高まりにより、大きな成長を遂げています。このような急成長の主因は、メディアによる広範な報道に支えられた、さまざまな健康状態に関する認識向上と教育イニシアティブです。技術革新、特に次世代シーケンシング（NGS）は、遺伝子検査のスピード、精度、手頃な価格を劇的に改善しました。しかし、遺伝子情報の悪用や保険・雇用分野での差別の可能性など、倫理的な問題やプライバシーに関する課題に直面しています。このようなハードルにもかかわらず、遺伝子検査の応用範囲の拡大とゲノミクスの進行中の進歩は、市場に大きな成長機会をもたらし、個別化医療とヘルスケアソリューションの有望な未来を示唆しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

遺伝子検査市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 次世代シーケンシング
• アレイテクノロジー
• PCRベースの検査
• FISH検査
• その他

遺伝子検査市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 祖先と民族
• 特性スクリーニング
• 遺伝性疾患キャリアステータス
• 新生児スクリーニング
• 健康とウェルネス-素因/リスク/傾向

遺伝子検査市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 消耗品
• 装置
• ソフトウェアとサービス

遺伝子検査市場規模：チャネル別& CAGR（2025-2032）

• 市場概要
• オンライン
• オフライン

遺伝子検査市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院・クリニック
• 診断検査室
• その他

遺伝子検査市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Illumina, Inc.（USA）
• Roche Holding AG（Switzerland）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN N.V.（Netherlands）
• Abbott Laboratories（USA）
• Agilent Technologies, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Danaher Corporation（USA）
• Myriad Genetics, Inc.（USA）
• 23andMe, Inc.（USA）
• Invitae Corporation（USA）
• Natera, Inc.（USA）
• NeoGenomics, Inc.（USA）
• Guardant Health, Inc.（USA）
• Siemens Healthineers AG（Germany）
• Hologic, Inc.（USA）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific（Luxembourg）
• Adaptive Biotechnologies Corporation（USA）

結論と提言

Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).

The genetic testing market has experienced significant growth due to advancements in technology, increasing healthcare demands, and heightened public awareness. This surge is primarily driven by enhanced awareness and educational initiatives about various prevalent health conditions, supported by extensive media coverage. Technological innovations, particularly in Next-Generation Sequencing (NGS), have drastically improved the speed, accuracy, and affordability of genetic tests. However, the market faces challenges regarding ethical concerns and privacy issues, including the potential misuse of genetic information and discrimination from insurance or employment sectors. Despite these hurdles, the expanding applications of genetic testing and ongoing advancements in genomics present substantial growth opportunities for the market, signaling a promising future in personalized medicine and healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Genetic Testing Market Segments Analysis

Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region. Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR - based Testing, FISH and Others. Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness - Predisposition/ Risk / Tendency. Based on Product, the market is segmented into Consumables, Equipment and Software & Services. Based on Channel, the market is segmented into Online and Offline. Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Genetic Testing Market

The global genetic testing market is significantly propelled by the increasing awareness and demand for personalized medicine. As individuals become more informed about the benefits of tailored healthcare solutions, there is a substantial shift towards genetic testing, which provides valuable insights into a person's unique genetic makeup. This heightened awareness fosters a growing preference for personalized treatment plans that can enhance efficacy and minimize adverse effects. Additionally, advancements in technology and the consequential reduction in testing costs have further fueled consumer interest. Consequently, the focus on personalized approaches in medicine continuously drives the expansion of the genetic testing sector worldwide.

Restraints in the Global Genetic Testing Market

One of the significant challenges facing the global genetic testing market is the issue of limited insurance coverage. Many insurance providers are hesitant to fully cover genetic testing expenses, often due to high costs and perceived uncertainties regarding the benefits of various tests. This lack of comprehensive coverage can deter individuals from seeking necessary genetic assessments, as out-of-pocket expenses may be prohibitive for many patients. Consequently, this restriction hampers market growth by limiting access to testing services, which in turn affects patient outcomes and the overall demand for advancements in genetic testing technologies and services.

Market Trends of the Global Genetic Testing Market

The Global Genetic Testing market is witnessing a significant trend of expanding beyond traditional DNA analysis to incorporate advanced methodologies, including RNA profiling and epigenetic testing. This evolution is pivotal as it enhances the detection of genetic variations and provides profound insights into how these alterations influence gene expression and overall health. By considering factors that do not alter the DNA sequence yet affect cellular functionality, genetic testing is becoming more comprehensive and personalized. This trend is expected to drive demand for innovative testing solutions, ultimately leading to more precise healthcare interventions and tailored treatments, thereby propelling market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Genetic Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Next Generation Sequencing
• Array Technology
• PCR - based Testing
• FISH
• Others

Global Genetic Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Ancestry & Ethnicity
• Traits Screening
• Genetic Disease Carrier Status
• New Baby Screening
• Health and Wellness - Predisposition/ Risk / Tendency

Global Genetic Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Equipment
• Software & Services

Global Genetic Testing Market Size by Channel & CAGR (2025-2032)

• Market Overview
• Online
• Offline

Global Genetic Testing Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Global Genetic Testing Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Channel, End Use)
  • US
  • Canada
• Europe (Technology, Application, Product, Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 23andMe, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptive Biotechnologies Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations